LINDSEY FORSTIE: Open Payments
NPI 1487174926 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 5 companies in 2025. Trend: 2023 $215 · 2024 $421 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $93 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: DUPIXENT, NEFFY, AIRSUPRA, XOLAIR.
Industry payments across AZ — which companies pay providers there.
